HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Meglumin
N-METHYL-D-GLUCAMINE · N-METHYLGLUCAMINE · Methylglucamine · Meglumin · 1-deoxy-1-(methylamino)-d-glucito · (2R,3R,4R,5S)-6-(MethylaMino)hexane-1,2,3,4,5-pentaol · 1-DEOXY-1-(METHYLAMINO)-D-GLUCITOL · MeguMine

Identifikatoren & physikalische Daten
| CAS No. | 6284-40-8 |
|---|---|
| Summenformel | C7H17NO5 |
| Durchschnittliche Molmasse | 195,21 g/mol |
| Monoisotopische Masse | 195,11067264 g/mol |
| SMILES | CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |
| InChIKey | MBBZMMPHUWSWHV-BDVNFPICSA-N |
| PubChem CID | 8567 |
| ChEMBL | CHEMBL1200570 |
| ChEBI | CHEBI:59732 |
| EC No. | 228-506-9 |
| DTXSID | DTXSID0023244 |
| Lokaler Name | Meglumin |
Chemische & physikalische Eigenschaften
| XLogP | -2,8 |
|---|---|
| Polarare Oberfläche (TPSA) | 113 |
| H-Brücken-Donoren | 6 |
| H-Brücken-Akzeptoren | 6 |
| Frei drehbare Bindungen | 6 |
| Schwere Atome | 13 |
| Formalladung | 0 |
| Komplexität | 134 |
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15 |
| Kosmetika | Hair conditioning |
| Human Drugs | FDA approved drugs -> Active ingredient |
| Animal Drugs | Pharmaceuticals -> UK Veterinary Medicines Directorate List |
| Physical Description | Dry PowderLiquid |
| Dissociation Constants | 9.6 |
| Collision Cross Section | 141.3 Ų [M+H]+ [CCS Type: DTBuffer gas: N2Ionization: ESI+Dataset: TOXCASTSource Identifier: DTXSID0023244]134.31 Ų [M+H-H2O]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]139 Ų [M+H]+ [CCS Type: TW |
| Schmelzpunkt | 129-131.5 °C (lit.) |
| Siedepunkt | 331.88°C (rough estimate) |
| Dichte | 1.2669 (rough estimate) |
| Brechungsindex | -16.5 ° (C=2, H2O) |
| Lagerbedingungen | 2-8°C |
| Löslichkeit | H2O: 0.1 g/mL, clear, colorless100 g/100 mL (25 ºC) |
| Aggregatzustand | Crystalline Powder |
| pKa (Säurekonstante) | pKa 9.39(H2O,t =30.0,I=0.05N2)(Approximate) |
| Farbe | White to almost white |
| pH | 11 (10g/l, H2O, 20℃) |
| Biologische Quelle | synthetic (organic) |
| Merck | 14,6078 |
| BRN | 385906 |
| Hauptanwendungen | pharmaceutical (small molecule) |
| Kosmetik-Inhaltsstoffe Funktionen | HAIR CONDITIONING |
| InChI | 1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1 |
| InChIKey | MBBZMMPHUWSWHV-VZFHVOOUSA-N |
| SMILES | CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |
| LogP (Verteilungskoeffizient) | -3.370 (est) |
| NIST chemische Informationen | N-methylglucamine(6284-40-8) |
| EPA chemische Informationen | Meglumine (6284-40-8) |
Sicherheit & Vorschriften
| GHS-Einstufung | This chemical does not meet GHS hazard criteria for 93.4% (425 of 455) of all reports.Not ClassifiedAggregated GHS information provided per 455 reports by companies from 7 notifications to the ECHA C&L Inventory. |
|---|---|
| Regulatorische Informationen | Chemical: D-Glucitol, 1-deoxy-1-(methylamino)-D-Glucitol, 1-deoxy-1-(methylamino)- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of D-Glucitol, 1-deoxy-1-(methylamino)- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)Status: Active Update: 13-02-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/18480Meglumine: Does not have an individual approval but may be used under an appropriate group standard |
| Hazard Classes and Categories | Not Classified |
| F | 3-10-23 |
| Wassergefährdungsklasse (WGK) | 3 |
| TSCA-Inventar-Status | TSCA listed |
| Zollcode | 29221980 |
| R-Sätze (R) | 36/37/38 |
| Toxizität | LD50 orally in Rabbit: > 5000 mg/kg |
| Sicherheitshinweise (S) | 24/25 |
| Lagerklasse | 11 - Combustible Solids |
| Selbstentzündungstemperatur | ~662 °F |
Anwendungen & Verwendung
Verwenden
N-Methyl-D-glucamine is used in conjunction with iodinated organic compounds in contrast media viz. diatrizoate meglumine and iodipamide meglumine. It is useful in ion-exchange resins to chelate boron ions selectively. It is also used as an excipient in pharmaceuticals, in cosmetics and X-ray contrast media. It is also employed in the synthesis of surface active agents, pharmaceuticals and dyes.